Sunday , May 22 2022

800,000 dollars awarded in the Wellington cancer fight



[ad_1]

A life-saving weapon in the fight against cancer is only 800,000 dollars closer to reality in New Zealand.

The clinical director of the Wellington Institute, Malaghan Robert Veinkove, was published as one of the latest funding circuits for the Health Research Council in which he paid $ 10 million.

The $ 802,249 assigned to Veinkove for five years was the highest of 61 grants announced on Tuesday.

Robert Veink and researcher Evelin Hide are part of the research team.

ROSS GIBLIN / STUFF

Robert Veink and researcher Evelin Hide are part of the research team.

Veink's will use this money to develop experimental carcinoma treatments known as CAR-T cell therapy, treatment with potential for cancer targeting, but proven to be the most effective in B-cell cancer tests, such as leukemia, lymphoma, and myeloma.

MORE:
* A $ 1 million campaign to treat cancer
* K + A: A lymph that killed Martin Crove
* Adverse effects of hemorrhoids
* Cancer is treated for 20 years in the making

The Institute is currently exploring a new version of CAR T-cell therapy, which is described as a revolutionary new cancer treatment that redirects its own immune cells to the patient in the fight against this disease. There is a clinical trial planned for 2019.

David Dovns, rightly, spent about $ 1 million traveling to the United States for the treatment of cancer. It was hoped that the $ 800,000 assigned to the Malaghan Clinical Director of the Institute, Robert Vinkove, left, would make the treatment more accessible to New Zealand.

FORD MONITOR FORD / STUFF

David Dovns, rightly, spent about $ 1 million traveling to the United States for the treatment of cancer. It was hoped that the $ 800,000 assigned to the Malaghan Clinical Director of the Institute, Robert Vinkove, left, would make the treatment more accessible to New Zealand.

"I expect to help make progress in basic research and clinical trials of CAR T cells, and I'm looking forward to helping introducing this type of treatment to New Zealand in the future," Veinkove said.

It was almost exactly a year ago – on November 26, 2017 – that Newspaper David Dovns was told about his rare form of cancer of the blood, lymphoma, that means he had a year to live.

But I talked Things on Monday he was very alive, in remission, and in Boston, the United States for one of his three-month reviews.

Robert Veinkove said the five-year funding grant was "a unique and fantastic opportunity".

ROSS GIBLIN / STUFF

Robert Veinkove said the five-year funding grant was "a unique and fantastic opportunity".

He attributed the CAR-T cell therapy he received in the United States to remain alive. While he was able to spend nearly a million dollars on treatment in the United States, news of HRC funding for New Zealand was "tremendous progress."

That move would be a major step towards the treatment of clinical trials in New Zealand and, I hope, means that New Zealanders would be able to access $ 1m USD and travel to the United States.

Veinkove said a five-year funding grant provided a "unique and fantastic opportunity" for experienced clinicians to conduct detailed research. It will also allow researchers to focus on the clinical needs of patients, not just research or clinical trials.

Malaghan Institute of Medical Research leads to new cancer therapy.

SUPPLIED

Malaghan Institute of Medical Research leads to new cancer therapy.

"These are issues that are really important for patients. Maybe it's a bit harder to find through other roots of funding."

Commercial treatment should be approved by various regulatory bodies, but Veink hopes to be available within a few years.

It has already become available in the US and parts of Europe, and potentially in Australia soon.

"We need to prepare our regulatory agencies – our institutions, our hospitals – to provide this treatment.

"One way to do this is to initiate our own clinical trials, but also by helping agencies like Pharmac see how we can implement it in practice."

[ad_2]
Source link